“SEC.gov Releases Statement from Mohit Verma”

The case before us revolves around insider trading conducted by Verma involving the securities of ImmunityBio, Inc. Verma’s actions took place prior to the public announcement of ImmunityBio’s…

In recent developments, it has come to light that Verma engaged in illicit insider trading activities related to the securities of ImmunityBio, Inc. This occurred prior to the public disclosure of important information about the company…

Verma’s involvement in insider trading with respect to ImmunityBio, Inc.’s stock has been brought to the forefront. It has been revealed that Verma engaged in these activities prior to the public release of significant information regarding the company…

The situation at hand involves Verma’s misconduct in insider trading involving the securities of ImmunityBio, Inc. Verma’s actions occurred prior to the public announcement of key information about the company…

The focus of the current proceedings is on Verma’s illegal insider trading activities concerning ImmunityBio, Inc.’s securities. These actions took place before the public disclosure of crucial information about the company…

It has been uncovered that Verma engaged in insider trading involving the securities of ImmunityBio, Inc. This misconduct occurred before pertinent information about the company was made public…

Verma’s involvement in insider trading with relation to ImmunityBio, Inc.’s securities has been revealed. Verma’s actions took place prior to the public announcement of important information about the company…

The case in question concerns Verma’s insider trading activities involving the securities of ImmunityBio, Inc. Verma’s wrongdoing occurred before the public disclosure of significant information about the company…